Press Releases

• 3 Aug, 2021 08:30 CEST
  Spago Nanomedical appoints Paul Hargreaves as Chief Development Officer
• 5 May, 2021 15:31 CEST
  Bulletin from the 2021 Annual General Meeting of Spago Nanomedical AB (publ)
• 28 Apr, 2021 09:21 CEST
  Spago Nanomedical interim report January-March 2021
• 26 Mar, 2021 08:25 CET
  Trading of Spago Nanomedical shares on Nasdaq First North Growth market starts today
• 7 Dec, 2020 10:27 CET
  Extended SpagoPix patent protection in Europe